Variant report

Variant	nsv435697
Chromosome Location	chr19:41354322-41388128
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:360)
CpG islands
(count:427)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:360 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41370633-41370945	K562	blood:	n/a	n/a
2	ARID3A	chr19:41378197-41378436	K562	blood:	n/a	n/a
3	ATF1	chr19:41378237-41378485	K562	blood:	n/a	n/a
4	ATF1	chr19:41370536-41370948	K562	blood:	n/a	n/a
5	ATF3	chr19:41370620-41370877	K562	blood:	n/a	n/a
6	ATF3	chr19:41378141-41378430	K562	blood:	n/a	n/a
7	CBX3	chr19:41379769-41380227	K562	blood:	n/a	n/a
8	CBX3	chr19:41370123-41371107	K562	blood:	n/a	n/a
9	CBX3	chr19:41379821-41380148	K562	blood:	n/a	n/a
10	CBX3	chr19:41381255-41381833	K562	blood:	n/a	n/a
11	CCNT2	chr19:41370582-41370786	K562	blood:	n/a	n/a
12	CEBPB	chr19:41378139-41378466	K562	blood:	n/a	n/a
13	CEBPB	chr19:41370543-41370910	K562	blood:	n/a	n/a
14	CEBPB	chr19:41368416-41368601	K562	blood:	n/a	n/a
15	CEBPB	chr19:41368480-41368982	A549	lung:	n/a	n/a
16	CEBPB	chr19:41367289-41367476	A549	lung:	n/a	n/a
17	CEBPB	chr19:41374056-41374100	A549	lung:	n/a	n/a
18	CEBPB	chr19:41373834-41374300	A549	lung:	n/a	n/a
19	CEBPB	chr19:41368761-41369068	Hela-S3	cervix:	n/a	n/a
20	CEBPB	chr19:41378202-41378474	K562	blood:	n/a	n/a
21	CEBPB	chr19:41370305-41370801	K562	blood:	n/a	chr19:41370433-41370441
22	CEBPB	chr19:41362024-41362201	K562	blood:	n/a	n/a
23	CEBPB	chr19:41373920-41374208	K562	blood:	n/a	n/a
24	CEBPB	chr19:41370209-41371189	K562	blood:	n/a	chr19:41370433-41370441
25	CEBPD	chr19:41370661-41370862	K562	blood:	n/a	n/a
26	CEBPD	chr19:41370295-41371143	K562	blood:	n/a	n/a
27	CTCF	chr19:41368380-41368530	HPAF	blood vessel:	n/a	n/a
28	CTCF	chr19:41354322-41355358	A549	lung:	n/a	chr19:41355271-41355289 chr19:41354699-41354709
29	CTCF	chr19:41364176-41364245	MCF-7	breast:	n/a	n/a
30	CTCF	chr19:41386211-41386665	K562	blood:	n/a	n/a
31	CTCF	chr19:41354435-41354719	H1-hESC	embryonic stem cell:	n/a	chr19:41354699-41354709
32	CTCF	chr19:41383928-41383999	LNCaP	prostate:	n/a	n/a
33	CTCF	chr19:41354520-41354670	HRE	kidney:	n/a	n/a
34	CTCF	chr19:41354302-41354800	A549	lung:	n/a	chr19:41354699-41354709
35	CTCF	chr19:41368300-41368450	AG04450	lung:	n/a	n/a
36	CTCF	chr19:41354520-41354670	HCFaa	heart:	n/a	n/a
37	CTCF	chr19:41354488-41354703	IMR90	lung:	n/a	n/a
38	CTCF	chr19:41354500-41354650	HCM	heart:	n/a	n/a
39	CTCF	chr19:41364120-41364270	K562	blood:	n/a	n/a
40	CTCF	chr19:41368340-41368490	AoAF	blood vessel:	n/a	n/a
41	CTCF	chr19:41364120-41364270	Caco-2	colon:	n/a	n/a
42	CTCF	chr19:41368320-41368470	HVMF	connective:	n/a	n/a
43	CTCF	chr19:41368260-41368410	HVMF	connective:	n/a	n/a
44	CTCF	chr19:41354520-41354670	HEK293	kidney:	n/a	n/a
45	CTCF	chr19:41354580-41354730	HVMF	connective:	n/a	chr19:41354699-41354709
46	CTCF	chr19:41368300-41368450	MCF-7	breast:	n/a	n/a
47	CTCF	chr19:41354521-41354653	ProgFib	skin:	n/a	n/a
48	CTCF	chr19:41360494-41360547	Kidney_OC	kidney:	n/a	n/a
49	CTCF	chr19:41359824-41359874	LNCaP	prostate:	n/a	n/a
50	CTCF	chr19:41364080-41364230	A549	lung:	n/a	n/a

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41355973-41356023	HIPEpiC	eye:	n/a
2	chr19:41385865-41385915	SK-N-MC	brain:	n/a
3	chr19:41386441-41386491	AG04449	skin:	fetal
4	chr19:41386441-41386491	HRE	kidney:	n/a
5	chr19:41385865-41385915	MCF-7	breast:	n/a
6	chr19:41355973-41356023	HepG2	liver:	n/a
7	chr19:41383654-41383704	NHDF-neo	bronchial:	n/a
8	chr19:41385865-41385915	HCM	heart:	n/a
9	chr19:41386507-41386557	Hepatocyte	liver:	n/a
10	chr19:41386507-41386557	HEEpiC	esophagus:	n/a
11	chr19:41386507-41386557	HNPCEpiC	eye:	n/a
12	chr19:41385865-41385915	HPAEpiC	pulmonary alveolar:	n/a
13	chr19:41386507-41386557	NHDF-neo	bronchial:	n/a
14	chr19:41386507-41386557	SKMC	muscle:	n/a
15	chr19:41355973-41356023	U87	brain:	n/a
16	chr19:41386507-41386557	NHBE	bronchial:	n/a
17	chr19:41385865-41385915	AG04449	skin:	fetal
18	chr19:41386507-41386557	SK-N-MC	brain:	n/a
19	chr19:41383654-41383704	A549	lung:	n/a
20	chr19:41354553-41354603	ovcar-3	ovarian:	n/a
21	chr19:41383654-41383704	HRE	kidney:	n/a
22	chr19:41354682-41354732	HCM	heart:	n/a
23	chr19:41354682-41354732	HCF	heart:	n/a
24	chr19:41354553-41354603	HCM	heart:	n/a
25	chr19:41354553-41354603	BJ	skin:	n/a
26	chr19:41354682-41354732	PANC-1	pancreas:	n/a
27	chr19:41354553-41354603	NT2-D1	testis:	n/a
28	chr19:41355973-41356023	AG04449	skin:	fetal
29	chr19:41383654-41383704	SKMC	muscle:	n/a
30	chr19:41354682-41354732	MCF10A-Er-Src	breast:	n/a
31	chr19:41383654-41383704	Hepatocyte	liver:	n/a
32	chr19:41355973-41356023	BE2_C	brain:	n/a
33	chr19:41383654-41383704	ProgFib	skin:	n/a
34	chr19:41354682-41354732	GM12878	blood:	n/a
35	chr19:41385865-41385915	NB4	blood:	n/a
36	chr19:41386507-41386557	HUVEC	blood vessel:	n/a
37	chr19:41386441-41386491	SK-N-SH_RA	brain:	n/a
38	chr19:41354553-41354603	SKMC	muscle:	n/a
39	chr19:41354553-41354603	NHBE	bronchial:	n/a
40	chr19:41385865-41385915	GM12891	blood:	n/a
41	chr19:41386441-41386491	HEK293	kidney:	embryo
42	chr19:41385865-41385915	AG09309	skin:	n/a
43	chr19:41354553-41354603	SK-N-SH	brain:	n/a
44	chr19:41386441-41386491	SAEC	small airway:	n/a
45	chr19:41385865-41385915	GM12892	blood:	n/a
46	chr19:41386507-41386557	BJ	skin:	n/a
47	chr19:41386441-41386491	NHDF-neo	bronchial:	n/a
48	chr19:41386507-41386557	BE2_C	brain:	n/a
49	chr19:41354682-41354732	T-47D	breast:	n/a
50	chr19:41383654-41383704	PrEC	prostate:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41195484..41197379-chr19:41368669..41371255,2	K562	blood:
2	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
3	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:

No data

Variant related genes	Relation type
CYP2A6	TF binding region
CYP2A7	TF binding region
CYP2A6	CpG island
CYP2A7	CpG island
ENSG00000105245	chromatin interactions

Extended variants
information (count: 1793 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:1793 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs372268476	chr19:41354335-41354336	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs572206869	chr19:41354344-41354345	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs577696506	chr19:41354418-41354419	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs57607700	chr19:41354442-41354443	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs560107238	chr19:41354444-41354445	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs557923713	chr19:41354457-41354458	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs28399442	chr19:41354458-41354459	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs374657291	chr19:41354474-41354475	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs368934082	chr19:41354475-41354476	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs372648888	chr19:41354483-41354484	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs8192726	chr19:41354496-41354497	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs369373560	chr19:41354514-41354515	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs1801272	chr19:41354533-41354534	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	disease
14	rs60563539	chr19:41354534-41354535	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs60605885	chr19:41354538-41354539	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs28399441	chr19:41354553-41354554	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs2545783	chr19:41354555-41354556	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs200354522	chr19:41354557-41354558	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs60996254	chr19:41354561-41354562	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs200793736	chr19:41354576-41354577	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs4986892	chr19:41354606-41354607	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs139707574	chr19:41354610-41354611	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs143626489	chr19:41354616-41354617	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs59552350	chr19:41354621-41354622	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs535832503	chr19:41354622-41354623	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs554865113	chr19:41354626-41354627	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs4986891	chr19:41354629-41354630	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs537280653	chr19:41354634-41354635	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs373566142	chr19:41354639-41354640	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs61562160	chr19:41354651-41354652	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs28399440	chr19:41354660-41354661	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs79584535	chr19:41354661-41354662	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs376782364	chr19:41354666-41354667	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs72547583	chr19:41354669-41354670	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs577758165	chr19:41354682-41354683	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs148803816	chr19:41354688-41354689	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
37	rs201873185	chr19:41354689-41354690	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs371146023	chr19:41354699-41354700	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs200390640	chr19:41354702-41354703	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs572417875	chr19:41354704-41354705	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs8192725	chr19:41354712-41354713	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs561651970	chr19:41354726-41354727	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs370272750	chr19:41354731-41354732	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
44	rs567115644	chr19:41354733-41354734	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs531895004	chr19:41354773-41354774	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs531139871	chr19:41354780-41354781	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs549252695	chr19:41354798-41354799	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs72549438	chr19:41354846-41354847	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs548652766	chr19:41354873-41354874	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs71173689	chr19:41354881-41354882	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:259 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41350600-41354400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
2	chr19:41350800-41354400	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
3	chr19:41351000-41354600	Weak transcription	Primary T killer memory cells from peripheral blood	blood
4	chr19:41351200-41354400	Weak transcription	Primary T helper naive cells from peripheral blood	blood
5	chr19:41351200-41354400	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
6	chr19:41352800-41354400	Weak transcription	Pancreas	Pancrea
7	chr19:41353600-41354800	Enhancers	Lung	lung
8	chr19:41353800-41354800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
9	chr19:41354000-41354800	Enhancers	Spleen	Spleen
10	chr19:41354200-41354400	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
11	chr19:41354200-41354400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
12	chr19:41354200-41354400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
13	chr19:41354200-41354400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr19:41354200-41354400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
15	chr19:41354200-41354400	Enhancers	Ovary	ovary
16	chr19:41354200-41354600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
17	chr19:41354200-41354600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr19:41354200-41354600	Flanking Active TSS	Liver	Liver
19	chr19:41354200-41354800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
20	chr19:41354200-41354800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
21	chr19:41354200-41354800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
22	chr19:41354200-41354800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
23	chr19:41354200-41355000	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
24	chr19:41354200-41355000	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
25	chr19:41354400-41354600	Flanking Bivalent TSS/Enh	Primary T helper cells PMA-I stimulated	--
26	chr19:41354400-41354600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
27	chr19:41354400-41354600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
28	chr19:41354400-41354600	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
29	chr19:41354400-41354600	Bivalent Enhancer	Fetal Brain Male	brain
30	chr19:41354400-41354600	Flanking Active TSS	Ovary	ovary
31	chr19:41354400-41354600	Enhancers	Rectal Smooth Muscle	rectum
32	chr19:41354400-41354600	Enhancers	Right Ventricle	heart
33	chr19:41354400-41354600	Bivalent Enhancer	Stomach Mucosa	stomach
34	chr19:41354400-41354800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
35	chr19:41354400-41354800	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr19:41354400-41354800	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
37	chr19:41354400-41354800	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
38	chr19:41354400-41354800	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
39	chr19:41354400-41354800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
40	chr19:41354400-41354800	Active TSS	Brain Angular Gyrus	brain
41	chr19:41354400-41354800	Enhancers	Brain Hippocampus Middle	brain
42	chr19:41354400-41354800	Active TSS	Brain Inferior Temporal Lobe	brain
43	chr19:41354400-41354800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
44	chr19:41354400-41354800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
45	chr19:41354400-41354800	Enhancers	Gastric	stomach
46	chr19:41354400-41354800	Enhancers	Pancreas	Pancrea
47	chr19:41354400-41354800	Enhancers	Right Atrium	heart
48	chr19:41354400-41355000	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
49	chr19:41354400-41355000	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
50	chr19:41354400-41355000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links